Skip to content

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06250725
Acronym
SLEEPMATE
Enrollment
80
Registered
2024-02-09
Start date
2024-08-01
Completion date
2026-09-01
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Sleep Disturbance

Keywords

Persons living with dementia (PLwD), Caregivers, Cognitive Behavioral Therapy for Insomnia (CBTi)

Brief summary

The purpose of this study is to determine if a 6-week videoconference intervention to teach skills to improve sleep is practical, acceptable, and helpful to persons living with memory loss, cognitive impairment, and/or dementia and care partners, individually or together.

Detailed description

Disturbed sleep is stressful to persons living with dementia (PLwD) and their caregivers. It contributes to the earlier placement of the PLwD in nursing homes and increases the risk for many psychological and cognitive health issues and poor quality of life for both the PLwD and the caregivers. Given the potential harmful side effects of medications, non-medication alternatives, such as Cognitive Behavioral Therapy for Insomnia (CBTi), may be safer to improve disturbed sleep in this population. CBTi which includes stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring, is effective and has durable and sustained effects on sleep outcomes over the long term. CBTi has improved sleep disturbances in PLwD and their caregivers, separately. Since disturbed sleep in the PLwD-caregiver dyad is bidirectional and interdependent, targeting the pair as a unit for intervention has the potential to lead to improved sleep and health outcomes for both persons. There is no current published research on CBTi when the PLwD and their caregivers receive the intervention at the same time; as a result, the research team aims to examine the 1) feasibility and 2) preliminary efficacy of 6-week CBTi intervention for community-dwelling PLwD and their caregivers who are both experiencing sleep disturbances. PLwD-caregiver dyads will participate in videoconferencing sessions. In addition, semi-structured interviews will take place to examine the acceptability and satisfaction with the intervention.

Interventions

BEHAVIORALCognitive Behavioral Therapy for Insomnia

The intervention protocol will include CBTi principles like stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring. It will be done over 6 weeks with one session weekly via videoconference.

Sponsors

Emory University
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for the PLwCI: * Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), or caregiver-reported probable or possible cognitive impairment or * Montreal Cognitive Assessment (MOCA) score between 12 and 24; * Had ≥1 sleep problem ≥3x/week on the Neuropsychiatric Inventory (NPI)-Nighttime Behavior Subscale; * Have an eligible caregiver; * Be able to participate in the intervention sessions Inclusion Criteria for Caregivers: * ≥18 years old, co-residing with persons living with cognitive impairment (PLwCI); * Regularly assist the care recipient with ≥1 of 7 basic activities of daily living or * ≥1 of 7 Instrumental Activities of Daily Living for the past 6 months; * Have difficulty falling asleep or difficulty staying asleep for the last three months or * Have a Pittsburgh Sleep Quality Index (PSQI) of 5 or greater

Exclusion criteria

* PLwCI: Moderate to severe cognitive impairment * Individuals who are not yet adults * Pregnant women * Prisoners * Individuals who are not able to clearly understand English.

Design outcomes

Primary

MeasureTime frameDescription
Change in insomniaBaseline, 1-week post-intervention, and 3 months post-interventionInsomnia will be measured using the Insomnia Severity Index. The insomnia severity index ahs seven questions. The seven answers are added up to get a total score. Total score categories: 0-7= No clinically significant insomnia 8-14= Subthreshold insomnia 15-21= Clinical insomnia (moderate severity) 22-28= Clinical insomnia (Severe)
Change in Sleep EfficiencyBaseline, 1-week post-intervention, and 3 months post-interventionSleep Efficiency will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.
Change in in Sleep Onset LatencyBaseline, 1-week post-intervention, and 3 months post-interventionSleep onset latency will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.
Change in Wake After Sleep OnsetBaseline, 1-week post-intervention, and 3 months post-interventionWake after sleep onset will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.
Adherence with Study Interventions (feasibility)weekly during the intervention period up to 3 months post-interventionFeasibility of the interventions will be assessed with rates of adherence to the study components throughout the study participation.
Satisfaction with intervention components1 week post-interventionSatisfaction with the intervention components will be assessed with the study satisfaction measure questionnaire that has 16 questions type that uses an agree, disagree scale as a range of answer options that go from strongly agree to strongly disagree.

Secondary

MeasureTime frameDescription
Change in depressionBaseline, 1-week post-intervention, and 3 months post-interventionDepression will be measured using the Center for Epidemiologic Studies Depression scale. The Center for Epidemiologic Studies Depression scale has 20 questions. The 20 answers are added up to get a total score between 0 and 60. Total score categories: 16 or greater = Clinically significant depressive symptoms
Change in the Quality of LifeBaseline, 1-week post-intervention, and 3 months post-interventionQuality of Life will be measured using the research and development (RAND) Medical Outcomes short form (SF)-36. The insomnia severity index has 36 questions which have subscales that total 100. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Countries

United States

Contacts

CONTACTGlenna S Brewster, PhD, RN, FNP
glenna.brewster@emory.edu(404) 712-9164
PRINCIPAL_INVESTIGATORGlenna Brewster, PhD, RN, FNP

Emory University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026